Connect with us

GSK on Facebook GSK on Twitter GSK on Flickr GSK on YouTube

To help millions of people

live longer, healthier lives

That's why we work at GSK

Save money on your prescriptions

Prescription savings programs

Recent headlines

June 06, 2013
GSK statement in response to FDA Advisory Committee’s vote on availability of Avandia (rosiglitazone)

June 01, 2013
GSK announces late-stage clinical data for VOTRIENT® (pazopanib) following chemotherapy in women with advanced epithelial ovarian cancer

May 30, 2013
National Survey Uncovers the Truth about Partial Dentures, Finds Few are Doing Enough to Ensure that their Partial Dentures are Always in Good Condition

May 29, 2013
Two new GSK oral oncology treatments, BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets, approved by FDA as single-agent therapies

[an error occurred while processing this directive]

GSK News ServicesGSK US Press Releases: RSS Feed

What are RSS feeds?

Information for Investors

Information for US Healthcare Professionals

Visit GSKSource.com

Full Discosure

Our work with the healthcare and nonprofit communities

Clinical Trial Information

Paxil (paroxetine) Information

 


Updated April 18, 2013
© 2001 - 2013 GlaxoSmithKline - All rights reserved